Table 1.
Age | |||||
Range | 33–98 | ||||
Mean | 65,34 | ||||
Sex | |||||
Male | 289 | ||||
Female | 85 | ||||
Ethnic group | |||||
Caucasian White | 286 | ||||
American White | 61 | ||||
Hispanic | 19 | ||||
American Black | 8 | ||||
Site | |||||
Trigonous (Tr) | 14 | ||||
Tongue (T) | 168 | ||||
Gums (G) | 18 | ||||
Cheek (C)* | 34 | ||||
Lip (L) | 29 | ||||
Bone Involvement (BI)** | 23 | ||||
Oropharynx (OP) | 4 | ||||
Palate (P) | 12 | ||||
Floor of the mouth (FOM) | 46 | ||||
Multiple sites (MS)*** | 11 | ||||
Metastasis (Met)**** | 15 | ||||
Total | 374 | ||||
Maximum diameter (cm) | |||||
<2 cm | 102 | ||||
>2 cm | 272 | ||||
| |||||
TNM staging | |||||
| |||||
T | N0 M0 | N0 M1 | N1 M0 | N1 M1 | Total |
| |||||
T1 | 86 | 3 | 25 | 3 | 117 |
T2 | 72 | 0 | 57 | 7 | 136 |
T3 | 13 | 0 | 29 | 8 | 50 |
T4 | 25 | 1 | 39 | 6 | 71 |
Total | 196 | 4 | 150 | 24 | 374 |
| |||||
Stage | |||||
St1 | 86 | ||||
St2 | 72 | ||||
St3 | 124 | ||||
St4 | 92 | ||||
Histologic grade | |||||
G1 | 62 | ||||
G2 | 188 | ||||
G3 | 124 | ||||
Follow-up | |||||
Alive | 142 | ||||
Dead for disease | 207 | ||||
Dead for other causes | 25 | ||||
Local recurrence | |||||
No | 215 | ||||
Yes | 159 | ||||
Therapy | |||||
CH | 233 | ||||
CH-RT/CH-RT-CHT | 59 | ||||
RT | 82 |
Legend: *Cheek includes gingival mucosa.
**Bone involvement of mandible or upper alveolar process.
***Multiple sites includes FM + Tr, T + Tr, T + G, C + L, T + C, T + L.
****Metastases analyzed without primary tumors due to not operable advanced stages primary cancer.